"Clin Exp Vaccine Res"[ Journal] - Search Results

Year	Number of Results
2012	11
2013	37
2014	29
2015	26
2016	24
2017	21
2018	18
2019	18
2020	24
2021	40
2022	39
2023	22

1

Immunogenicity of the ChAdOx1 nCoV-19 vaccine in patients with hematologic malignancies.

Thookhamme C, Navinpipat M, Sasakul A, Pattarakosol P, Lertchaisataporn K, Tawinprai K, Praditsuktavorn P. Thookhamme C, et al. Clin Exp Vaccine Res. 2023 Apr;12(2):107-115. doi: 10.7774/cevr.2023.12.2.107. Epub 2023 Apr 30. Clin Exp Vaccine Res. 2023. PMID: 37214149 Free PMC article.

2

Detection of immunity in sheep following anti-rabies vaccination.

Rathnadiwakara H, Gunatilake M, Cliquet F, Wasniewski M, Thammitiyagodage M, Karunakaran R, Thibault JC, Ijas M. Rathnadiwakara H, et al. Clin Exp Vaccine Res. 2023 Apr;12(2):97-106. doi: 10.7774/cevr.2023.12.2.97. Epub 2023 Apr 30. Clin Exp Vaccine Res. 2023. PMID: 37214148 Free PMC article.

3

Nondaily dosing schedule of allergen-specific sublingual immunotherapy: efficacy and safety.

Abdelwahab HW, Abd El-Maksoud A. Abdelwahab HW, et al. Clin Exp Vaccine Res. 2023 Apr;12(2):121-126. doi: 10.7774/cevr.2023.12.2.121. Epub 2023 Apr 30. Clin Exp Vaccine Res. 2023. PMID: 37214147 Free PMC article.

4

Occurrence of erythema multiforme following COVID-19 vaccination: a review.

Yousefian M, Khadivi A. Yousefian M, et al. Clin Exp Vaccine Res. 2023 Apr;12(2):87-96. doi: 10.7774/cevr.2023.12.2.87. Epub 2023 Apr 30. Clin Exp Vaccine Res. 2023. PMID: 37214146 Free PMC article. Review.

5

Pregnant women's knowledge about and beliefs toward COVID-19 vaccine: a cross-sectional study.

Gunkaya OS, Tekin AB, Yassa M, Arslan O, Karakoç K, Demirtaş N, Usta C, Künt İşgüder Ç, Tuğ N. Gunkaya OS, et al. Clin Exp Vaccine Res. 2023 Apr;12(2):134-142. doi: 10.7774/cevr.2023.12.2.134. Epub 2023 Apr 30. Clin Exp Vaccine Res. 2023. PMID: 37214145 Free PMC article.

6

Changes in SARS-CoV-2 antibody titers 6 months after the booster dose of BNT162b2 COVID-19 vaccine among health care workers.

Mochizuki T, Hori T, Yano K, Ikari K, Okazaki K. Mochizuki T, et al. Clin Exp Vaccine Res. 2023 Apr;12(2):116-120. doi: 10.7774/cevr.2023.12.2.116. Epub 2023 Apr 30. Clin Exp Vaccine Res. 2023. PMID: 37214144 Free PMC article.

7

Strategic construction of mRNA vaccine derived from conserved and experimentally validated epitopes of avian influenza type A virus: a reverse vaccinology approach.

Herrera-Ong LR. Herrera-Ong LR. Clin Exp Vaccine Res. 2023 Apr;12(2):156-171. doi: 10.7774/cevr.2023.12.2.156. Epub 2023 Apr 30. Clin Exp Vaccine Res. 2023. PMID: 37214143 Free PMC article.

8

Exploring the underlying factors of COVID-19 vaccination hesitancy in Ahvaz, Iran: a comprehensive cross-sectional study.

Afshari P, Alavi SM, Abedi P, Beheshtinasab M, Dashtpayma S, Amiri H. Afshari P, et al. Clin Exp Vaccine Res. 2023 Apr;12(2):127-133. doi: 10.7774/cevr.2023.12.2.127. Epub 2023 Apr 30. Clin Exp Vaccine Res. 2023. PMID: 37214142 Free PMC article.

9

Disseminated life-threatening viral skin rash in a child with atopic dermatitis.

Herzum A, Occella C, Garibeh E, Gariazzo L, Viglizzo G. Herzum A, et al. Clin Exp Vaccine Res. 2023 Apr;12(2):176-178. doi: 10.7774/cevr.2023.12.2.176. Epub 2023 Apr 30. Clin Exp Vaccine Res. 2023. PMID: 37214141 Free PMC article.

10

Guillain-Barré syndrome associated with SARS-CoV-2 vaccination: how is it different? a systematic review and individual participant data meta-analysis.

Reddy YM, Murthy JM, Osman S, Jaiswal SK, Gattu AK, Pidaparthi L, Boorgu SK, Chavan R, Ramakrishnan B, Yeduguri SR. Reddy YM, et al. Clin Exp Vaccine Res. 2023 Apr;12(2):143-155. doi: 10.7774/cevr.2023.12.2.143. Epub 2023 Apr 30. Clin Exp Vaccine Res. 2023. PMID: 37214140 Free PMC article.

11

A case report overlapped vaccine and COVID-19 in disseminated atherosclerosis.

Bayrak V. Bayrak V. Clin Exp Vaccine Res. 2023 Apr;12(2):172-175. doi: 10.7774/cevr.2023.12.2.172. Epub 2023 Apr 30. Clin Exp Vaccine Res. 2023. PMID: 37214139 Free PMC article.

12

Individual expression and processing of hepatitis C virus E1/E2 epitopes-based DNA vaccine candidate in healthy humans' peripheral blood mononuclear cells.

Nadeem R, Maghraby AS, Abd-Elshafy DN, Barakat AB, Bahgat MM. Nadeem R, et al. Clin Exp Vaccine Res. 2023 Jan;12(1):47-59. doi: 10.7774/cevr.2023.12.1.47. Epub 2023 Jan 31. Clin Exp Vaccine Res. 2023. PMID: 36844691 Free PMC article.

13

Comparative evaluation of gold nanoparticles and Alum as immune enhancers against rabies vaccine and related immune reactivity, physiological, and histopathological alterations: in vivo study.

El-Hennamy REE, Mahmoud SM, El-Yamany NA, Hassanein HH, Amer ME, Mohamed AF. El-Hennamy REE, et al. Clin Exp Vaccine Res. 2023 Jan;12(1):32-46. doi: 10.7774/cevr.2023.12.1.32. Epub 2023 Jan 31. Clin Exp Vaccine Res. 2023. PMID: 36844690 Free PMC article.

14

Herpes zoster ophthalmicus after COVID-19 vaccine booster in healthy younger adult: a case report.

Awaly ZWN. Awaly ZWN. Clin Exp Vaccine Res. 2023 Jan;12(1):82-84. doi: 10.7774/cevr.2023.12.1.82. Epub 2023 Jan 31. Clin Exp Vaccine Res. 2023. PMID: 36844689 Free PMC article.

15

Adverse events following immunisation with the first dose of sputnik V among Iranian health care providers.

Jafarzadeh Esfehani R, Zahmatkesh M, Goldozian R, Farkhonde J, Jaripour E, Hatami A, Bidkhori HR, Shamsian SK, Shamsian SA, Mojahedi F. Jafarzadeh Esfehani R, et al. Clin Exp Vaccine Res. 2023 Jan;12(1):25-31. doi: 10.7774/cevr.2023.12.1.25. Epub 2023 Jan 31. Clin Exp Vaccine Res. 2023. PMID: 36844688 Free PMC article.

16

Exploring the experience of developing COVID-19 vaccines in Iran.

Ghanei M, Mohabattalab A, Fartash K, Kolahchi N, Khakdaman A, Kaghazian H, Bagheri A. Ghanei M, et al. Clin Exp Vaccine Res. 2023 Jan;12(1):1-12. doi: 10.7774/cevr.2023.12.1.1. Epub 2023 Jan 31. Clin Exp Vaccine Res. 2023. PMID: 36844687 Free PMC article. Review.

17

Before blaming SARS-CoV-2 vaccines for thalamic lacunar stroke, alternative etiologies must be ruled out.

Finsterer J. Finsterer J. Clin Exp Vaccine Res. 2023 Jan;12(1):85-86. doi: 10.7774/cevr.2023.12.1.85. Epub 2023 Jan 31. Clin Exp Vaccine Res. 2023. PMID: 36844686 Free PMC article. No abstract available.

18

Humoral immune response to SARS-CoV-2 mRNA vaccines is associated with choice of vaccine and systemic adverse reactions.

Klingel H, Krüttgen A, Imöhl M, Kleines M. Klingel H, et al. Clin Exp Vaccine Res. 2023 Jan;12(1):60-69. doi: 10.7774/cevr.2023.12.1.60. Epub 2023 Jan 31. Clin Exp Vaccine Res. 2023. PMID: 36844685 Free PMC article.

19

New typhoid vaccine using sponge-like reduced protocol: development and evaluation.

Bahy R, Gaber A, Zedan H, Mabrook M. Bahy R, et al. Clin Exp Vaccine Res. 2023 Jan;12(1):70-76. doi: 10.7774/cevr.2023.12.1.70. Epub 2023 Jan 31. Clin Exp Vaccine Res. 2023. PMID: 36844684 Free PMC article.

20

The threat of Monkeypox in the Philippines: another problematic preparation and management for the healthcare system?

Cordero DA Jr. Cordero DA Jr. Clin Exp Vaccine Res. 2023 Jan;12(1):77-79. doi: 10.7774/cevr.2023.12.1.77. Epub 2023 Jan 31. Clin Exp Vaccine Res. 2023. PMID: 36844683 Free PMC article.

21

Seroconversion rates in kidney transplant recipients following SARS-CoV-2 vaccination and its association with immunosuppressive agents: a systematic review and meta-analysis.

Iryaningrum MR, Cahyadi A, Damara FA, Bandiara R, Marbun MBH. Iryaningrum MR, et al. Clin Exp Vaccine Res. 2023 Jan;12(1):13-24. doi: 10.7774/cevr.2023.12.1.13. Epub 2023 Jan 31. Clin Exp Vaccine Res. 2023. PMID: 36844682 Free PMC article. Review.

22

Psoriasis flares after COVID-19 vaccination: adherence to biologic therapy reduces psoriasis exacerbations: a case-control study.

Burlando M, Herzum A, Cozzani E, Parodi A. Burlando M, et al. Clin Exp Vaccine Res. 2023 Jan;12(1):80-81. doi: 10.7774/cevr.2023.12.1.80. Epub 2023 Jan 31. Clin Exp Vaccine Res. 2023. PMID: 36844681 Free PMC article.

23

Deep vein thrombosis and acute hepatitis after ChAdOx1 nCov-19 vaccination in a Charcot-Marie-Tooth patient: a case report.

Napoli R, Visonà E. Napoli R, et al. Clin Exp Vaccine Res. 2022 Sep;11(3):294-297. doi: 10.7774/cevr.2022.11.3.294. Epub 2022 Sep 30. Clin Exp Vaccine Res. 2022. PMID: 36451672 Free PMC article.

24

Livedo reticularis following administration of ChAdOx1 nCoV-19 vaccine (AZD1222): a report of two cases.

Kim JH, Uh JA, Kim HS, Lee SK, Kim MS, Lee UH. Kim JH, et al. Clin Exp Vaccine Res. 2022 Sep;11(3):298-301. doi: 10.7774/cevr.2022.11.3.298. Epub 2022 Sep 30. Clin Exp Vaccine Res. 2022. PMID: 36451671 Free PMC article.

25

Identifying immunodominant multi-epitopes from the envelope glycoprotein of the Lassa mammarenavirus as vaccine candidate for Lassa fever.

Rowaiye AB, Nwonu EJ, Asala TM, Ogu AC, Bur D, Chukwu C, Oli AN, Agbalalah T. Rowaiye AB, et al. Clin Exp Vaccine Res. 2022 Sep;11(3):249-263. doi: 10.7774/cevr.2022.11.3.249. Epub 2022 Sep 30. Clin Exp Vaccine Res. 2022. PMID: 36451670 Free PMC article.

26

Factors associated with intention to take COVID-19 vaccine among the university students in Bangladesh.

Shuvo NA, Mondal MSH. Shuvo NA, et al. Clin Exp Vaccine Res. 2022 Sep;11(3):274-284. doi: 10.7774/cevr.2022.11.3.274. Epub 2022 Sep 30. Clin Exp Vaccine Res. 2022. PMID: 36451669 Free PMC article.

27

Development of mucosal vaccine delivery: an overview on the mucosal vaccines and their adjuvants.

Anggraeni R, Ana ID, Wihadmadyatami H. Anggraeni R, et al. Clin Exp Vaccine Res. 2022 Sep;11(3):235-248. doi: 10.7774/cevr.2022.11.3.235. Epub 2022 Sep 30. Clin Exp Vaccine Res. 2022. PMID: 36451668 Free PMC article. Review.

28

Field evaluation of the safety and immunogenicity of a classical swine fever virus E2 subunit vaccine in breeding and nursery animals on Jeju Island, South Korea.

Jang G, Kim EJ, Cho SC, Moon SU, Kim BS, Kim J, Jeong KJ, Song K, Mun SH, Kang WM, Lee J, Park C, Yang HS, Lee C. Jang G, et al. Clin Exp Vaccine Res. 2022 Sep;11(3):264-273. doi: 10.7774/cevr.2022.11.3.264. Epub 2022 Sep 30. Clin Exp Vaccine Res. 2022. PMID: 36451667 Free PMC article.

29

COVID-19 vaccines development in Africa: a review of current situation and existing challenges of vaccine production.

Adeyemi O. Adeyemi O. Clin Exp Vaccine Res. 2022 Sep;11(3):302-303. doi: 10.7774/cevr.2022.11.3.302. Epub 2022 Sep 30. Clin Exp Vaccine Res. 2022. PMID: 36451666 Free PMC article. No abstract available.

30

Quick drop of platelet counts in children with chronic immune thrombocytopenia after COVID-19 mRNA vaccination: case reports.

Lassandro G, Carriero F, Palladino V, Del Vecchio GC, Giordano P. Lassandro G, et al. Clin Exp Vaccine Res. 2022 Sep;11(3):290-293. doi: 10.7774/cevr.2022.11.3.290. Epub 2022 Sep 30. Clin Exp Vaccine Res. 2022. PMID: 36451665 Free PMC article.

31

Recombinant proteins of spike protein of SARS-CoV-2 with the Omicron receptor-binding domain induce production of highly Omicron-specific neutralizing antibodies.

Kang H, Kim D, Min K, Park M, Kim SH, Sohn EJ, Choi BH, Hwang I. Kang H, et al. Clin Exp Vaccine Res. 2022 Sep;11(3):285-289. doi: 10.7774/cevr.2022.11.3.285. Epub 2022 Sep 30. Clin Exp Vaccine Res. 2022. PMID: 36451664 Free PMC article.

32

Unmasking the COVID-19 vaccination myths: intervention through collaboration.

Cordero DA Jr. Cordero DA Jr. Clin Exp Vaccine Res. 2022 Sep;11(3):304-305. doi: 10.7774/cevr.2022.11.3.304. Epub 2022 Sep 30. Clin Exp Vaccine Res. 2022. PMID: 36451663 Free PMC article. No abstract available.

33

Exploring the myths surrounding the COVID-19 vaccines in Africa: the study to investigate their impacts on acceptance using online survey and social media.

Lamptey E, Senkyire EK, Dorcas S, Benita DA, Boakye EO, Ikome T, Asamoah A. Lamptey E, et al. Clin Exp Vaccine Res. 2022 May;11(2):193-208. doi: 10.7774/cevr.2022.11.2.193. Epub 2022 May 31. Clin Exp Vaccine Res. 2022. PMID: 35799880 Free PMC article.

34

Evaluation of precipitation time of the aluminum salts adsorbed potentially frozen vaccines used in the Polish National Immunization Schedule for their pre-qualification before the administration.

Górska P, Główka M, Woźnica K, Zasada AA. Górska P, et al. Clin Exp Vaccine Res. 2022 May;11(2):155-162. doi: 10.7774/cevr.2022.11.2.155. Epub 2022 May 31. Clin Exp Vaccine Res. 2022. PMID: 35799879 Free PMC article.

35

COVID-19 vaccination policies and the new challenges of international travel.

Ramírez C, Choi JN, Durón RM. Ramírez C, et al. Clin Exp Vaccine Res. 2022 May;11(2):230-232. doi: 10.7774/cevr.2022.11.2.230. Epub 2022 May 31. Clin Exp Vaccine Res. 2022. PMID: 35799878 Free PMC article. No abstract available.

36

Thalamic hemi-chorea: a rare complication after receiving the adenoviral vector-based COVID-19 vaccine: a case report.

Shahali H, Farahani RH, Asgari A, Hazrati E. Shahali H, et al. Clin Exp Vaccine Res. 2022 May;11(2):217-221. doi: 10.7774/cevr.2022.11.2.217. Epub 2022 May 31. Clin Exp Vaccine Res. 2022. PMID: 35799877 Free PMC article.

37

SARS-CoV-2 vaccine challenge based on spike glycoprotein against several new variants.

Syahniar R, Kharisma DS. Syahniar R, et al. Clin Exp Vaccine Res. 2022 May;11(2):173-183. doi: 10.7774/cevr.2022.11.2.173. Epub 2022 May 31. Clin Exp Vaccine Res. 2022. PMID: 35799876 Free PMC article. Review.

38

Adult vaccine-related knowledge, attitudes, and behaviors in Turkey.

Karaoğlu SA, Taş BG, Toprak D. Karaoğlu SA, et al. Clin Exp Vaccine Res. 2022 May;11(2):133-140. doi: 10.7774/cevr.2022.11.2.133. Epub 2022 May 31. Clin Exp Vaccine Res. 2022. PMID: 35799875 Free PMC article.

39

Exploring interventions against COVID-19 vaccine hesitancy in the Philippines.

Cordero DA Jr. Cordero DA Jr. Clin Exp Vaccine Res. 2022 May;11(2):233-234. doi: 10.7774/cevr.2022.11.2.233. Epub 2022 May 31. Clin Exp Vaccine Res. 2022. PMID: 35799874 Free PMC article. No abstract available.

40

A survey of healthcare workers' recommendations about human papillomavirus vaccination.

Nishioka H, Onishi T, Kitano T, Takeyama M, Imakita N, Kasahara K, Kawaguchi R, Masaki JA, Nogami K. Nishioka H, et al. Clin Exp Vaccine Res. 2022 May;11(2):149-154. doi: 10.7774/cevr.2022.11.2.149. Epub 2022 May 31. Clin Exp Vaccine Res. 2022. PMID: 35799873 Free PMC article.

41

Subacute thyroiditis after receiving the vaccine for COVID-19: a case report and literature review.

Vu TB, Chu DT, Le DT, Hoang TTD, Gautret P, Hoang VT. Vu TB, et al. Clin Exp Vaccine Res. 2022 May;11(2):226-229. doi: 10.7774/cevr.2022.11.2.226. Epub 2022 May 31. Clin Exp Vaccine Res. 2022. PMID: 35799872 Free PMC article.

42

Epstein-Barr virus reactivation after COVID-19 vaccination in a young immunocompetent man: a case report.

Herzum A, Trave I, D'Agostino F, Burlando M, Cozzani E, Parodi A. Herzum A, et al. Clin Exp Vaccine Res. 2022 May;11(2):222-225. doi: 10.7774/cevr.2022.11.2.222. Epub 2022 May 31. Clin Exp Vaccine Res. 2022. PMID: 35799871 Free PMC article.

43

Heterologous prime-boost with the mRNA-1273 vaccine among CoronaVac-vaccinated healthcare workers in Indonesia.

Santi T, Sungono V, Kamarga L, Samakto B, Hidayat F, Hidayat FK, Satolom M, Permana A, Yusuf I, Suriapranata IM, Jo J. Santi T, et al. Clin Exp Vaccine Res. 2022 May;11(2):209-216. doi: 10.7774/cevr.2022.11.2.209. Epub 2022 May 31. Clin Exp Vaccine Res. 2022. PMID: 35799870 Free PMC article.

44

Nasal vaccine as a booster shot: a viable solution to restrict pandemic?

Meenakshi S, Kumar VU, Dhingra S, Murti K. Meenakshi S, et al. Clin Exp Vaccine Res. 2022 May;11(2):184-192. doi: 10.7774/cevr.2022.11.2.184. Epub 2022 May 31. Clin Exp Vaccine Res. 2022. PMID: 35799869 Free PMC article. Review.

45

Formulation of an ovarian cancer vaccine with the squalene-based AddaVax adjuvant inhibits the growth of murine epithelial ovarian carcinomas.

Mazumder S, Swank V, Dvorina N, Johnson JM, Tuohy VK. Mazumder S, et al. Clin Exp Vaccine Res. 2022 May;11(2):163-172. doi: 10.7774/cevr.2022.11.2.163. Epub 2022 May 31. Clin Exp Vaccine Res. 2022. PMID: 35799868 Free PMC article.

46

Possible different genotypes for human papillomavirus vaccination in lower middle-income countries towards cervical cancer elimination in 2030: a cross-sectional study.

Utami TW, Andrijono A, Putra A, Indarti J, Fleuren G, Jordanova E, Humairah I, Utomo A. Utami TW, et al. Clin Exp Vaccine Res. 2022 May;11(2):141-148. doi: 10.7774/cevr.2022.11.2.141. Epub 2022 May 31. Clin Exp Vaccine Res. 2022. PMID: 35799867 Free PMC article.

47

Alopecia areata after COVID-19 vaccination.

Gallo G, Mastorino L, Tonella L, Ribero S, Quaglino P. Gallo G, et al. Clin Exp Vaccine Res. 2022 Jan;11(1):129-132. doi: 10.7774/cevr.2022.11.1.129. Epub 2022 Jan 31. Clin Exp Vaccine Res. 2022. PMID: 35223675 Free PMC article.

48

The risk of confusion between AstraZeneka COVID-19 vaccine side effects and signs of COVID-19 infection: a case report.

Nomali M, Afzali M. Nomali M, et al. Clin Exp Vaccine Res. 2022 Jan;11(1):125-128. doi: 10.7774/cevr.2022.11.1.125. Epub 2022 Jan 31. Clin Exp Vaccine Res. 2022. PMID: 35223674 Free PMC article.

49

Severity of adverse reactions is associated with T-cell response in mRNA-1273 vaccinated health care workers.

Klingel H, Lauen M, Krüttgen A, Imöhl M, Kleines M. Klingel H, et al. Clin Exp Vaccine Res. 2022 Jan;11(1):121-124. doi: 10.7774/cevr.2022.11.1.121. Epub 2022 Jan 31. Clin Exp Vaccine Res. 2022. PMID: 35223673 Free PMC article.

50

Assessment on anti-SARS-CoV-2 receptor-binding domain antibodies among CoronaVac-vaccinated Indonesian adults.

Jo J, Sanjaya A, Pinontoan R, Aruan M, Wahyuni RM, Viktaria V. Jo J, et al. Clin Exp Vaccine Res. 2022 Jan;11(1):116-120. doi: 10.7774/cevr.2022.11.1.116. Epub 2022 Jan 31. Clin Exp Vaccine Res. 2022. PMID: 35223672 Free PMC article.

51

Reactogenicity to COVID-19 vaccination in the United States of America.

Sanyaolu A, Marinkovic A, Prakash S, Desai P, Haider N, Abbasi AF, Mehraban N, Jain I, Ekeh A, Shazley O, Okorie C, Orish VN. Sanyaolu A, et al. Clin Exp Vaccine Res. 2022 Jan;11(1):104-115. doi: 10.7774/cevr.2022.11.1.104. Epub 2022 Jan 31. Clin Exp Vaccine Res. 2022. PMID: 35223671 Free PMC article.

52

Large inter-individual variability of cellular and humoral immunological responses to mRNA-1273 (Moderna) vaccination against SARS-CoV-2 in health care workers.

Krüttgen A, Haase G, Haefner H, Imöhl M, Kleines M. Krüttgen A, et al. Clin Exp Vaccine Res. 2022 Jan;11(1):96-103. doi: 10.7774/cevr.2022.11.1.96. Epub 2022 Jan 31. Clin Exp Vaccine Res. 2022. PMID: 35223670 Free PMC article.

53

Factors associated with side effects of COVID-19 vaccine in Indonesia.

Wibowo J, Heriyanto RS, Wijovi F, Halim DA, Claudia C, Marcella E, Susanto B, Indrawan M, Heryadi NK, Imanuelly M, Anurantha JJ, Hariyanto TI, Marcellin C, Sinaga TD, Rizki SA, Sieto N, Siregar JI, Lugito NPH, Kurniawan A. Wibowo J, et al. Clin Exp Vaccine Res. 2022 Jan;11(1):89-95. doi: 10.7774/cevr.2022.11.1.89. Epub 2022 Jan 31. Clin Exp Vaccine Res. 2022. PMID: 35223669 Free PMC article.

54

COVID-19 vaccines development in Africa: a review of current situation and existing challenges of vaccine production.

Lamptey E, Senkyire EK, Benita DA, Boakye EO. Lamptey E, et al. Clin Exp Vaccine Res. 2022 Jan;11(1):82-88. doi: 10.7774/cevr.2022.11.1.82. Epub 2022 Jan 31. Clin Exp Vaccine Res. 2022. PMID: 35223668 Free PMC article. Review.

55

Successful seroconversion against diphtheria and tetanus induced through maternal vaccination in a region of Colombia.

Hincapie-Palacio D, Echeverri A, Hoyos C, Vargas-Restrepo F, Ospina M, Buitrago S, Ochoa J. Hincapie-Palacio D, et al. Clin Exp Vaccine Res. 2022 Jan;11(1):72-81. doi: 10.7774/cevr.2022.11.1.72. Epub 2022 Jan 31. Clin Exp Vaccine Res. 2022. PMID: 35223667 Free PMC article.

56

Knowledge, attitude, and practices regarding human papillomavirus and its' vaccination among the young medical professionals and students of Bangladesh.

Chowdhury S, Ara R, Roy S, Tanvir SMS, Eva FN, Neela TM, Moonmoon AA, Sifat S, Zamila M, Hawlader MDH. Chowdhury S, et al. Clin Exp Vaccine Res. 2022 Jan;11(1):63-71. doi: 10.7774/cevr.2022.11.1.63. Epub 2022 Jan 31. Clin Exp Vaccine Res. 2022. PMID: 35223666 Free PMC article.

57

Protection against virulent Brucella spp. by gamma-irradiated B. ovis in BALB/c mice model.

Al-Mariri A, Al-Hallab L, Alabras R, Kherbik H, Khawajkiah M. Al-Mariri A, et al. Clin Exp Vaccine Res. 2022 Jan;11(1):53-62. doi: 10.7774/cevr.2022.11.1.53. Epub 2022 Jan 31. Clin Exp Vaccine Res. 2022. PMID: 35223665 Free PMC article.

58

Protectivity and safety following recombinant hepatitis B vaccine with different source of bulk compared to hepatitis B (Bio Farma) vaccine in Indonesia.

Nency YM, Rahmadi FA, Mulyono, Anantyo DT, Farhanah N, Hapsari R, Farida H, Sadhana U, Djagat H, Kristina TN, Juniarto AZ, Puspita M, Sari RM, Bachtiar NS. Nency YM, et al. Clin Exp Vaccine Res. 2022 Jan;11(1):43-52. doi: 10.7774/cevr.2022.11.1.43. Epub 2022 Jan 31. Clin Exp Vaccine Res. 2022. PMID: 35223664 Free PMC article.

59

Preparation and field study of combined vaccine against Clostridium perfringens type A and bovine viral diarrhea virus in camels.

Elhelw HA, El Fadeel MRA, El-Sergany E, Allam A, Elbayoumy MK, El-Kattan AM, El-Kholy AA. Elhelw HA, et al. Clin Exp Vaccine Res. 2022 Jan;11(1):30-42. doi: 10.7774/cevr.2022.11.1.30. Epub 2022 Jan 31. Clin Exp Vaccine Res. 2022. PMID: 35223663 Free PMC article.

60

Expression of full and fragment-B of diphtheria toxin genes in Escherichia coli for generating of recombinant diphtheria vaccines.

Abulmagd S, Khattab AEA, Zedan H. Abulmagd S, et al. Clin Exp Vaccine Res. 2022 Jan;11(1):12-29. doi: 10.7774/cevr.2022.11.1.12. Epub 2022 Jan 31. Clin Exp Vaccine Res. 2022. PMID: 35223662 Free PMC article.

61

Comparison and efficacy of two different sheep pox vaccines prepared from the Bakırköy strain against lumpy skin disease in cattle.

Uzar S, Sarac F, Gulyaz V, Enul H, Yılmaz H, Turan N. Uzar S, et al. Clin Exp Vaccine Res. 2022 Jan;11(1):1-11. doi: 10.7774/cevr.2022.11.1.1. Epub 2022 Jan 31. Clin Exp Vaccine Res. 2022. PMID: 35223661 Free PMC article.

62

Are the COVID-19's vaccines efficient on the most dangerous variant of SARS-CoV-2?

Davoodi P, Hashemi A. Davoodi P, et al. Clin Exp Vaccine Res. 2021 Sep;10(3):301-303. doi: 10.7774/cevr.2021.10.3.301. Epub 2021 Sep 30. Clin Exp Vaccine Res. 2021. PMID: 34703817 Free PMC article. No abstract available.

63

Acute urticarial rash after COVID-19 vaccination containing Polysorbate 80.

Burlando M, Herzum A, Cozzani E, Parodi A. Burlando M, et al. Clin Exp Vaccine Res. 2021 Sep;10(3):298-300. doi: 10.7774/cevr.2021.10.3.298. Epub 2021 Sep 30. Clin Exp Vaccine Res. 2021. PMID: 34703816 Free PMC article.

64

A case of acute encephalopathy and non-ST segment elevation myocardial infarction following mRNA-1273 vaccination: possible adverse effect?

Barsha SY, Akiful Haque MM, Rashid MU, Rahman ML, Hossain MA, Zaman S, Bhuiyan E, Sultana R, Hossian M, Nabi MH, Hawlader MDH. Barsha SY, et al. Clin Exp Vaccine Res. 2021 Sep;10(3):293-297. doi: 10.7774/cevr.2021.10.3.293. Epub 2021 Sep 30. Clin Exp Vaccine Res. 2021. PMID: 34703815 Free PMC article.

65

Shingles and mRNA COVID-19 vaccine.

Mungmunpuntipantip R, Wiwanitkit V. Mungmunpuntipantip R, et al. Clin Exp Vaccine Res. 2021 Sep;10(3):292. doi: 10.7774/cevr.2021.10.3.292. Epub 2021 Sep 30. Clin Exp Vaccine Res. 2021. PMID: 34703814 Free PMC article. No abstract available.

66

Challenges managing COVID vaccine-induced immune thrombotic thrombocytopenia in low-middle income countries.

Ramírez C, Hernández RJS, Durón RM. Ramírez C, et al. Clin Exp Vaccine Res. 2021 Sep;10(3):290-291. doi: 10.7774/cevr.2021.10.3.290. Epub 2021 Sep 30. Clin Exp Vaccine Res. 2021. PMID: 34703813 Free PMC article. No abstract available.

67

Reactogenicity after the first and second doses of BNT162b2 mRNA coronavirus disease vaccine: a single-center study.

Kang YM, Lim J, Choe KW, Lee KD, Jo DH, Kim MJ, Kim JM, Kim KN. Kang YM, et al. Clin Exp Vaccine Res. 2021 Sep;10(3):282-289. doi: 10.7774/cevr.2021.10.3.282. Epub 2021 Sep 30. Clin Exp Vaccine Res. 2021. PMID: 34703812 Free PMC article.

68

Severity of COVID-19 in bacillus Calmette-Guérin vaccinated population.

Khanum I, Kumar L, Awan S, Jamil B. Khanum I, et al. Clin Exp Vaccine Res. 2021 Sep;10(3):276-281. doi: 10.7774/cevr.2021.10.3.276. Epub 2021 Sep 30. Clin Exp Vaccine Res. 2021. PMID: 34703811 Free PMC article.

69

Post-vaccination COVID-19 deaths: a review of available evidence and recommendations for the global population.

Lamptey E. Lamptey E. Clin Exp Vaccine Res. 2021 Sep;10(3):264-275. doi: 10.7774/cevr.2021.10.3.264. Epub 2021 Sep 30. Clin Exp Vaccine Res. 2021. PMID: 34703810 Free PMC article. Review.

70

The effect of apolipoprotein A-I and perfluorocarbon emulsion on the production of specific antibodies in mice.

Zhalimov V, Gritsyna Y, Morenkov O. Zhalimov V, et al. Clin Exp Vaccine Res. 2021 Sep;10(3):259-263. doi: 10.7774/cevr.2021.10.3.259. Epub 2021 Sep 30. Clin Exp Vaccine Res. 2021. PMID: 34703809 Free PMC article.

71

Evaluation of the antigenic stability of influenza virus like particles after exposure to acidic or basic pH.

Kim SH, Park YC, Song JM. Kim SH, et al. Clin Exp Vaccine Res. 2021 Sep;10(3):252-258. doi: 10.7774/cevr.2021.10.3.252. Epub 2021 Sep 30. Clin Exp Vaccine Res. 2021. PMID: 34703808 Free PMC article.

72

Transient expression of fusion and hemagglutinin-neuraminidase epitopes of Newcastle disease virus in maize as a potent candidate vaccine.

Shahriari AG, Niazi A, Habibi-Pirkoohi M. Shahriari AG, et al. Clin Exp Vaccine Res. 2021 Sep;10(3):245-251. doi: 10.7774/cevr.2021.10.3.245. Epub 2021 Sep 30. Clin Exp Vaccine Res. 2021. PMID: 34703807 Free PMC article.

73

Vaccine usage and wastage in a designated Yellow Fever Vaccination Centre in North India.

Dkhar SA, Quansar R, Haq I, Khan SMS. Dkhar SA, et al. Clin Exp Vaccine Res. 2021 Sep;10(3):240-244. doi: 10.7774/cevr.2021.10.3.240. Epub 2021 Sep 30. Clin Exp Vaccine Res. 2021. PMID: 34703806 Free PMC article.

74

Staphylococcus aureus derived hyaluronic acid and bacillus Calmette-Guérin purified proteins as immune enhancers to rabies vaccine and related immuno-histopathological alterations.

Shebl RI, Amer ME, Abuamara TMM, Matar ER, Ahmed HF, Gomah TA, El Moselhy LE, Abu-Elghait M, Mohamed AF. Shebl RI, et al. Clin Exp Vaccine Res. 2021 Sep;10(3):229-239. doi: 10.7774/cevr.2021.10.3.229. Epub 2021 Sep 30. Clin Exp Vaccine Res. 2021. PMID: 34703805 Free PMC article.

75

Oral immunization of rat with chromosomal expression LipL32 in attenuated Salmonella vaccine induces immune respond against pathogenic Leptospira.

Samakchan N, Thinwang P, Boonyom R. Samakchan N, et al. Clin Exp Vaccine Res. 2021 Sep;10(3):217-228. doi: 10.7774/cevr.2021.10.3.217. Epub 2021 Sep 30. Clin Exp Vaccine Res. 2021. PMID: 34703804 Free PMC article.

76

Adverse events following pediatric immunization in an Indian city.

Paramkusham V, Palakurthy P, Gurram NS, Talla V, Vishwas HN, Jupally VR, Pattnaik S. Paramkusham V, et al. Clin Exp Vaccine Res. 2021 Sep;10(3):211-216. doi: 10.7774/cevr.2021.10.3.211. Epub 2021 Sep 30. Clin Exp Vaccine Res. 2021. PMID: 34703803 Free PMC article.

77

Parenteral, non-live rotavirus vaccine: recent history and future perspective.

Song JM. Song JM. Clin Exp Vaccine Res. 2021 Sep;10(3):203-210. doi: 10.7774/cevr.2021.10.3.203. Epub 2021 Sep 30. Clin Exp Vaccine Res. 2021. PMID: 34703802 Free PMC article. Review.

78

A rare case of shingles after COVID-19 vaccine: is it a possible adverse effect?

Aksu SB, Öztürk GZ. Aksu SB, et al. Clin Exp Vaccine Res. 2021 May;10(2):198-201. doi: 10.7774/cevr.2021.10.2.198. Epub 2021 May 31. Clin Exp Vaccine Res. 2021. PMID: 34222134 Free PMC article.

79

Acute myocarditis associated with anti-COVID-19 vaccination.

Nevet A. Nevet A. Clin Exp Vaccine Res. 2021 May;10(2):196-197. doi: 10.7774/cevr.2021.10.2.196. Epub 2021 May 31. Clin Exp Vaccine Res. 2021. PMID: 34222133 Free PMC article.

80

A possible protective role for Bacillus Calmette-Guérin therapy in urinary bladder cancer in the era of COVID-19: a brief report.

Ohadian Moghadam S, Abbasi B, Nowroozi A, Amini E, Nowroozi MR, Momeni SA, Niroomand H. Ohadian Moghadam S, et al. Clin Exp Vaccine Res. 2021 May;10(2):191-195. doi: 10.7774/cevr.2021.10.2.191. Epub 2021 May 31. Clin Exp Vaccine Res. 2021. PMID: 34222132 Free PMC article.

81

A nationwide survey of the potential acceptance and determinants of COVID-19 vaccines in Ghana.

Lamptey E, Serwaa D, Appiah AB. Lamptey E, et al. Clin Exp Vaccine Res. 2021 May;10(2):183-190. doi: 10.7774/cevr.2021.10.2.183. Epub 2021 May 31. Clin Exp Vaccine Res. 2021. PMID: 34222131 Free PMC article.

82

Determinants of the willingness of the general population to get vaccinated against COVID-19 in a developing country.

Al-Mistarehi AH, Kheirallah KA, Yassin A, Alomari S, Aledrisi MK, Bani Ata EM, Hammad NH, Khanfar AN, Ibnian AM, Khassawneh BY. Al-Mistarehi AH, et al. Clin Exp Vaccine Res. 2021 May;10(2):171-182. doi: 10.7774/cevr.2021.10.2.171. Epub 2021 May 31. Clin Exp Vaccine Res. 2021. PMID: 34222130 Free PMC article.

83

Inside the story about the research and development of COVID-19 vaccines.

Patel SP, Patel GS, Suthar JV. Patel SP, et al. Clin Exp Vaccine Res. 2021 May;10(2):154-170. doi: 10.7774/cevr.2021.10.2.154. Epub 2021 May 31. Clin Exp Vaccine Res. 2021. PMID: 34222129 Free PMC article. Review.

84

Fight against COVID-19 with mRNA vaccines and interaction with Dermal fillers.

Ghasemi S, Dashti M. Ghasemi S, et al. Clin Exp Vaccine Res. 2021 May;10(2):151-153. doi: 10.7774/cevr.2021.10.2.151. Epub 2021 May 31. Clin Exp Vaccine Res. 2021. PMID: 34222128 Free PMC article.

85

Vaccines are not one size fits all, just like medications: rotavirus vaccine study.

Varre JV. Varre JV. Clin Exp Vaccine Res. 2021 May;10(2):148-150. doi: 10.7774/cevr.2021.10.2.148. Epub 2021 May 31. Clin Exp Vaccine Res. 2021. PMID: 34222127 Free PMC article.

86

Immunogenicity of an inactivated rabies vaccine for animals derived from the recombinant ERAGS strain.

Yang DK, Kim HH, Park YR, Yoo JY, Park Y, An S, Hyun BH. Yang DK, et al. Clin Exp Vaccine Res. 2021 May;10(2):141-147. doi: 10.7774/cevr.2021.10.2.141. Epub 2021 May 31. Clin Exp Vaccine Res. 2021. PMID: 34222126 Free PMC article.

87

Outer membrane proteins of Salmonella typhimurium as an adjuvant in rabies vaccine.

Negm II, Ragab YM, Mohamed AF. Negm II, et al. Clin Exp Vaccine Res. 2021 May;10(2):132-140. doi: 10.7774/cevr.2021.10.2.132. Epub 2021 May 31. Clin Exp Vaccine Res. 2021. PMID: 34222125 Free PMC article.

88

Novel antigen panel for modern broad-spectrum recombinant rotavirus A vaccine.

Kondakova OA, Ivanov PA, Baranov OA, Ryabchevskaya EM, Arkhipenko MV, Skurat EV, Evtushenko EA, Nikitin NA, Karpova OV. Kondakova OA, et al. Clin Exp Vaccine Res. 2021 May;10(2):123-131. doi: 10.7774/cevr.2021.10.2.123. Epub 2021 May 31. Clin Exp Vaccine Res. 2021. PMID: 34222124 Free PMC article.

89

Immunogenicity of antigens from outer membrane vesicles of Neisseria meningitidis associated with bilayer fragment of dioctadecyldimethylammonium in Swiss adult mice.

Rinaldi FM, Gaspar EB, Brito LT, Gaspari E. Rinaldi FM, et al. Clin Exp Vaccine Res. 2021 May;10(2):106-122. doi: 10.7774/cevr.2021.10.2.106. Epub 2021 May 31. Clin Exp Vaccine Res. 2021. PMID: 34222123 Free PMC article.

90

Comparison of regulatory framework of clinical trial with genetically modified organism-containing vaccines in the Europe, Australia, and Switzerland.

Jose J, Pai S. Jose J, et al. Clin Exp Vaccine Res. 2021 May;10(2):93-105. doi: 10.7774/cevr.2021.10.2.93. Epub 2021 May 31. Clin Exp Vaccine Res. 2021. PMID: 34222122 Free PMC article. Review.

91

Impact of vaccination on carriage of and infection by antibiotic-resistant bacteria: a systematic review and meta-analysis.

Wang LM, Cravo Oliveira Hashiguchi T, Cecchini M. Wang LM, et al. Clin Exp Vaccine Res. 2021 May;10(2):81-92. doi: 10.7774/cevr.2021.10.2.81. Epub 2021 May 31. Clin Exp Vaccine Res. 2021. PMID: 34222121 Free PMC article. Review.

92

Pan-vasculitis and fulminant hepatitis following routine vaccination at the age of 4 months.

Awad MH, El-Hawary A, Sawah G, Nasef N. Awad MH, et al. Clin Exp Vaccine Res. 2021 Jan;10(1):78-80. doi: 10.7774/cevr.2021.10.1.78. Epub 2021 Jan 31. Clin Exp Vaccine Res. 2021. PMID: 33628757 Free PMC article.

93

Immunoinformatic analysis of immunogenic B- and T-cell epitopes of MIC4 protein to designing a vaccine candidate against Toxoplasma gondii through an in-silico approach.

Ghaffari AD, Dalimi A, Ghaffarifar F, Pirestani M, Majidiani H. Ghaffari AD, et al. Clin Exp Vaccine Res. 2021 Jan;10(1):59-77. doi: 10.7774/cevr.2021.10.1.59. Epub 2021 Jan 31. Clin Exp Vaccine Res. 2021. PMID: 33628756 Free PMC article.

94

Efficacy of physical and chemical treatments on the inactivation of bovine leukosis virus present in milk.

Sandoval-Monzón RS, Arévalo-Rodriguez ICK, Carrillo-Torres AA, Ruiz-García LF. Sandoval-Monzón RS, et al. Clin Exp Vaccine Res. 2021 Jan;10(1):52-58. doi: 10.7774/cevr.2021.10.1.52. Epub 2021 Jan 31. Clin Exp Vaccine Res. 2021. PMID: 33628755 Free PMC article.

95

A comparison of post vaccination hepatitis B surface antibody level on the large and appropriate for gestational age infants.

Esteghamati A, Sayyahfar S, Ghaemi H, Joulani M, Moradi Y, Talebi A. Esteghamati A, et al. Clin Exp Vaccine Res. 2021 Jan;10(1):47-51. doi: 10.7774/cevr.2021.10.1.47. Epub 2021 Jan 31. Clin Exp Vaccine Res. 2021. PMID: 33628754 Free PMC article.

96

Adverse events associated with Measles and Rubella vaccination campaign 2019 in India.

Sharma R, Gaur A. Sharma R, et al. Clin Exp Vaccine Res. 2021 Jan;10(1):44-46. doi: 10.7774/cevr.2021.10.1.44. Epub 2021 Jan 31. Clin Exp Vaccine Res. 2021. PMID: 33628753 Free PMC article.

97

Immunogenicity of glycine nanoparticles containing a chimeric antigen as Brucella vaccine candidate.

Karevan G, Ahmadi K, Taheri RA, Fasihi-Ramandi M. Karevan G, et al. Clin Exp Vaccine Res. 2021 Jan;10(1):35-43. doi: 10.7774/cevr.2021.10.1.35. Epub 2021 Jan 31. Clin Exp Vaccine Res. 2021. PMID: 33628752 Free PMC article.

98

Biological properties the novel application of N-trimethyl chitosan nanospheres as a stabilizer and preservative in tetanus vaccine.

Ghalavand M, Saadati M, Salimian J, Abbasi E, Hosseinzadeh G, Gouvarchin Ghaleh HE, Ahmadi A. Ghalavand M, et al. Clin Exp Vaccine Res. 2021 Jan;10(1):24-34. doi: 10.7774/cevr.2021.10.1.24. Epub 2021 Jan 31. Clin Exp Vaccine Res. 2021. PMID: 33628751 Free PMC article.

99

Current updates and research on plant-based vaccines for coronavirus disease 2019.

Uthaya Kumar A, Kadiresen K, Gan WC, Ling APK. Uthaya Kumar A, et al. Clin Exp Vaccine Res. 2021 Jan;10(1):13-23. doi: 10.7774/cevr.2021.10.1.13. Epub 2021 Jan 31. Clin Exp Vaccine Res. 2021. PMID: 33628750 Free PMC article. Review.

100

A review on the advancements in the development of vaccines to combat coronavirus disease 2019.

Onyeaka H, Al-Sharify ZT, Ghadhban MY, Al-Najjar SZ. Onyeaka H, et al. Clin Exp Vaccine Res. 2021 Jan;10(1):6-12. doi: 10.7774/cevr.2021.10.1.6. Epub 2021 Jan 31. Clin Exp Vaccine Res. 2021. PMID: 33628749 Free PMC article. Review.

101

Polyvaccine: joining the links in the cascade of type 1 diabetes.

Desai S, Bhonde RR, Parekh SS. Desai S, et al. Clin Exp Vaccine Res. 2021 Jan;10(1):1-5. doi: 10.7774/cevr.2021.10.1.1. Epub 2021 Jan 31. Clin Exp Vaccine Res. 2021. PMID: 33628748 Free PMC article. Review.

102

Is the impact of childhood vaccines on coronavirus disease 2019, which is moderate in pediatric patients, possible?

Bozkurt HB. Bozkurt HB. Clin Exp Vaccine Res. 2020 Jul;9(2):183-184. doi: 10.7774/cevr.2020.9.2.183. Epub 2020 Jul 31. Clin Exp Vaccine Res. 2020. PMID: 32864377 Free PMC article. No abstract available.

103

Current national policies for infant universal bacille Calmette-Guérin vaccination were associated with lower mortality from coronavirus disease 2019.

Ebina-Shibuya R, Horita N, Namkoong H, Kaneko T. Ebina-Shibuya R, et al. Clin Exp Vaccine Res. 2020 Jul;9(2):179-182. doi: 10.7774/cevr.2020.9.2.179. Epub 2020 Jul 31. Clin Exp Vaccine Res. 2020. PMID: 32864376 Free PMC article.

104

Potential use of 3-(trimethoxysilyl)propyldimethyl octadecyl ammonium chloride as an antimicrobial and antiviral agent for the disinfection of personal protective equipment.

Kim Y, Youn H, Kim J, Lee D, Go S, Park JE, Lee S, Noh J, Nahm SS. Kim Y, et al. Clin Exp Vaccine Res. 2020 Jul;9(2):174-178. doi: 10.7774/cevr.2020.9.2.174. Epub 2020 Jul 31. Clin Exp Vaccine Res. 2020. PMID: 32864375 Free PMC article.

105

Coronavirus epitope prediction from highly conserved region of spike protein.

Yurina V. Yurina V. Clin Exp Vaccine Res. 2020 Jul;9(2):169-173. doi: 10.7774/cevr.2020.9.2.169. Epub 2020 Jul 31. Clin Exp Vaccine Res. 2020. PMID: 32864374 Free PMC article.

106

An edible vaccine development for coronavirus disease 2019: the concept.

Sohrab SS. Sohrab SS. Clin Exp Vaccine Res. 2020 Jul;9(2):164-168. doi: 10.7774/cevr.2020.9.2.164. Epub 2020 Jul 31. Clin Exp Vaccine Res. 2020. PMID: 32864373 Free PMC article. Review.

107

Gemini lipopeptides as vaccine adjuvants: a new role for these versatile carriers.

Grippo LD, Reidel IG, García MI, Streu A, Müller DM, Veaute CM. Grippo LD, et al. Clin Exp Vaccine Res. 2020 Jul;9(2):159-163. doi: 10.7774/cevr.2020.9.2.159. Epub 2020 Jul 31. Clin Exp Vaccine Res. 2020. PMID: 32864372 Free PMC article.

108

In-depth computational analysis of calcium-dependent protein kinase 3 of Toxoplasma gondii provides promising targets for vaccination.

Majidiani H, Soltani S, Ghaffari AD, Sabaghan M, Taghipour A, Foroutan M. Majidiani H, et al. Clin Exp Vaccine Res. 2020 Jul;9(2):146-158. doi: 10.7774/cevr.2020.9.2.146. Epub 2020 Jul 31. Clin Exp Vaccine Res. 2020. PMID: 32864371 Free PMC article.

109

Investigation of adverse events following bacille Calmette-Guérin immunization using immunization safety surveillance system in Korea Centers for Disease Control and Prevention.

Roh EJ, Lee YK, Lee MH, Kim MK, Kim TE, Lee SG, Chung EH. Roh EJ, et al. Clin Exp Vaccine Res. 2020 Jul;9(2):133-145. doi: 10.7774/cevr.2020.9.2.133. Epub 2020 Jul 31. Clin Exp Vaccine Res. 2020. PMID: 32864370 Free PMC article.

110

Influence of temperature on the antigenic changes of virus-like particles.

Shin JI, Park YC, Song JM. Shin JI, et al. Clin Exp Vaccine Res. 2020 Jul;9(2):126-132. doi: 10.7774/cevr.2020.9.2.126. Epub 2020 Jul 31. Clin Exp Vaccine Res. 2020. PMID: 32864369 Free PMC article.

111

Preparation and efficacy of freeze-dried inactivated vaccine against bovine viral diarrhea virus genotypes 1 and 2, bovine herpes virus type 1.1, bovine parainfluenza-3 virus, and bovine respiratory syncytial virus.

Abd El Fadeel MR, El-Dakhly AT, Allam AM, Farag TK, El-Kholy AA. Abd El Fadeel MR, et al. Clin Exp Vaccine Res. 2020 Jul;9(2):119-125. doi: 10.7774/cevr.2020.9.2.119. Epub 2020 Jul 31. Clin Exp Vaccine Res. 2020. PMID: 32864368 Free PMC article.

112

Bluetongue virus viral protein 7 stability in the presence of glycerol and sodium chloride.

Russell BL, Gildenhuys S. Russell BL, et al. Clin Exp Vaccine Res. 2020 Jul;9(2):108-118. doi: 10.7774/cevr.2020.9.2.108. Epub 2020 Jul 31. Clin Exp Vaccine Res. 2020. PMID: 32864367 Free PMC article.

113

Genotype-specific neutralizing antibody titers against Japanese encephalitis virus genotypes 1 and 3 in horses immunized with a genotype 3 vaccine.

Kim HH, Yang DK, Ji M, Lee SK, Hyun BH. Kim HH, et al. Clin Exp Vaccine Res. 2020 Jul;9(2):102-107. doi: 10.7774/cevr.2020.9.2.102. Epub 2020 Jul 31. Clin Exp Vaccine Res. 2020. PMID: 32864366 Free PMC article.

114

Determination of non-structural protein level for Turkey foot-and-mouth disease vaccine antigens during in-process.

Sareyyüpoğlu B, Çokçalışkan C, Çoskuner A, Gülyaz V. Sareyyüpoğlu B, et al. Clin Exp Vaccine Res. 2020 Jul;9(2):97-101. doi: 10.7774/cevr.2020.9.2.97. Epub 2020 Jul 31. Clin Exp Vaccine Res. 2020. PMID: 32864365 Free PMC article.

115

Antigenic properties of dense granule antigen 12 protein using bioinformatics tools in order to improve vaccine design against Toxoplasma gondii.

Ghaffari AD, Dalimi A, Ghaffarifar F, Pirestani M. Ghaffari AD, et al. Clin Exp Vaccine Res. 2020 Jul;9(2):81-96. doi: 10.7774/cevr.2020.9.2.81. Epub 2020 Jul 31. Clin Exp Vaccine Res. 2020. PMID: 32864364 Free PMC article.

116

Autolysin (lytA) recombinant protein: a potential target for developing vaccines against pneumococcal infections.

Afshar D, Rafiee F, Kheirandish M, Ohadian Moghadam S, Azarsa M. Afshar D, et al. Clin Exp Vaccine Res. 2020 Jul;9(2):76-80. doi: 10.7774/cevr.2020.9.2.76. Epub 2020 Jul 31. Clin Exp Vaccine Res. 2020. PMID: 32864363 Free PMC article.

117

Vaccines in the United States: a systematic review on history of evolution, regulations, licensing, and future challenges.

Sathyanarayana SD, Fernandes SD, Castelino LJ, Vadakkepushpakath AN, Shriram RG. Sathyanarayana SD, et al. Clin Exp Vaccine Res. 2020 Jul;9(2):69-75. doi: 10.7774/cevr.2020.9.2.69. Epub 2020 Jul 31. Clin Exp Vaccine Res. 2020. PMID: 32864362 Free PMC article. Review.

118

Seroprevalence of mumps in healthcare workers in South Korea.

Kim SK, Jung J, Kwak SH, Hong MJ, Kim SH. Kim SK, et al. Clin Exp Vaccine Res. 2020 Jan;9(1):64-67. doi: 10.7774/cevr.2020.9.1.64. Epub 2020 Jan 31. Clin Exp Vaccine Res. 2020. PMID: 32095442 Free PMC article.

119

Comparison of antigenic mutation during egg and cell passage cultivation of H3N2 influenza virus.

Park YW, Kim YH, Jung HU, Jeong OS, Hong EJ, Kim H, Lee JI. Park YW, et al. Clin Exp Vaccine Res. 2020 Jan;9(1):56-63. doi: 10.7774/cevr.2020.9.1.56. Epub 2020 Jan 31. Clin Exp Vaccine Res. 2020. PMID: 32095441 Free PMC article.

120

Suspension culture of Vero cells for the production of adenovirus type 5.

Lee DK, Park J, Seo DW. Lee DK, et al. Clin Exp Vaccine Res. 2020 Jan;9(1):48-55. doi: 10.7774/cevr.2020.9.1.48. Epub 2020 Jan 31. Clin Exp Vaccine Res. 2020. PMID: 32095440 Free PMC article.

121

Immunogenicity of a new, inactivated canine adenovirus type 2 vaccine for dogs.

Yang DK, Kim HH, Yoo JY, Ji M, Han BH, Oh S, Hyun BH. Yang DK, et al. Clin Exp Vaccine Res. 2020 Jan;9(1):40-47. doi: 10.7774/cevr.2020.9.1.40. Epub 2020 Jan 31. Clin Exp Vaccine Res. 2020. PMID: 32095439 Free PMC article.

122

The potential efficacy of the E2-subunit vaccine to protect pigs against different genotypes of classical swine fever virus circulating in Vietnam.

Tran HTT, Truong DA, Ly VD, Vu HT, Hoang TV, Nguyen CT, Chu NT, Nguyen VT, Nguyen DT, Miyazawa K, Kokuho T, Dang HV. Tran HTT, et al. Clin Exp Vaccine Res. 2020 Jan;9(1):26-39. doi: 10.7774/cevr.2020.9.1.26. Epub 2020 Jan 31. Clin Exp Vaccine Res. 2020. PMID: 32095438 Free PMC article.

123

Reverse vaccinology approach for the identification and characterization of outer membrane proteins of Shigella flexneri as potential cellular- and antibody-dependent vaccine candidates.

Leow CY, Kazi A, Hisyam Ismail CMK, Chuah C, Lim BH, Leow CH, Banga Singh KK. Leow CY, et al. Clin Exp Vaccine Res. 2020 Jan;9(1):15-25. doi: 10.7774/cevr.2020.9.1.15. Epub 2020 Jan 31. Clin Exp Vaccine Res. 2020. PMID: 32095437 Free PMC article.

124

Cold chain time- and temperature-controlled transport of vaccines: a simulated experimental study.

Ng CZ, Lean YL, Yeoh SF, Lean QY, Lee KS, Suleiman AK, Liew KB, Kassab YW, Al-Worafi YM, Ming LC. Ng CZ, et al. Clin Exp Vaccine Res. 2020 Jan;9(1):8-14. doi: 10.7774/cevr.2020.9.1.8. Epub 2020 Jan 31. Clin Exp Vaccine Res. 2020. PMID: 32095436 Free PMC article.

125

Hepatitis B vaccination and immunotherapies: an update.

Stasi C, Silvestri C, Voller F. Stasi C, et al. Clin Exp Vaccine Res. 2020 Jan;9(1):1-7. doi: 10.7774/cevr.2020.9.1.1. Epub 2020 Jan 31. Clin Exp Vaccine Res. 2020. PMID: 32095435 Free PMC article. Review.

126

Plant factory: new resource for the productivity and diversity of human and veterinary vaccines.

Shim BS, Hong KJ, Maharjan PM, Choe S. Shim BS, et al. Clin Exp Vaccine Res. 2019 Jul;8(2):136-139. doi: 10.7774/cevr.2019.8.2.136. Epub 2019 Jul 31. Clin Exp Vaccine Res. 2019. PMID: 31406696 Free PMC article.

127

Rabies immune status of raccoon dogs residing in areas where rabies bait vaccine has been distributed.

Yang DK, Kim HH, Lee EJ, Yoo JY, Kim JT, Ahn S. Yang DK, et al. Clin Exp Vaccine Res. 2019 Jul;8(2):132-135. doi: 10.7774/cevr.2019.8.2.132. Epub 2019 Jul 31. Clin Exp Vaccine Res. 2019. PMID: 31406695 Free PMC article.

128

Transient expression of hemagglutinin antigen from canine influenza virus H3N2 in Nicotiana benthamiana and Lactuca sativa.

Maharjan PM, Choe S. Maharjan PM, et al. Clin Exp Vaccine Res. 2019 Jul;8(2):124-131. doi: 10.7774/cevr.2019.8.2.124. Epub 2019 Jul 31. Clin Exp Vaccine Res. 2019. PMID: 31406694 Free PMC article.

129

A clinico-epidemiological multicenter study of herpes zoster in immunocompetent and immunocompromised hospitalized children.

Hwang JH, Kim KH, Han SB, Kim HH, Kim JH, Lee SY, Choi UY, Kang JH. Hwang JH, et al. Clin Exp Vaccine Res. 2019 Jul;8(2):116-123. doi: 10.7774/cevr.2019.8.2.116. Epub 2019 Jul 31. Clin Exp Vaccine Res. 2019. PMID: 31406693 Free PMC article.

130

A meningococcal B vaccine induces cross-protection against gonorrhea.

Azze RFO. Azze RFO. Clin Exp Vaccine Res. 2019 Jul;8(2):110-115. doi: 10.7774/cevr.2019.8.2.110. Epub 2019 Jul 31. Clin Exp Vaccine Res. 2019. PMID: 31406692 Free PMC article.

131

Effect of simultaneous administration of foot-and-mouth disease (FMD) and anthrax vaccines on antibody response to FMD in sheep.

Çokçalışkan C, Tuncer Göktuna P, Türkoğlu T, Uzunlu E, Gündüzalp C, Uzun EA, Sareyyüpoğlu B, Kürkçü A, Gülyaz V. Çokçalışkan C, et al. Clin Exp Vaccine Res. 2019 Jul;8(2):103-109. doi: 10.7774/cevr.2019.8.2.103. Epub 2019 Jul 31. Clin Exp Vaccine Res. 2019. PMID: 31406691 Free PMC article.

132

One-year antibody persistence and safety of a 4-dose schedule of MenACWY-CRM in healthy infants from South Korea.

Lee HJ, Jo DS, Kim YK, Lee H, Kim KH, Lee D, Curina C, Costantini M, Barbi S, Miao Y, Pellegrini M. Lee HJ, et al. Clin Exp Vaccine Res. 2019 Jul;8(2):94-102. doi: 10.7774/cevr.2019.8.2.94. Epub 2019 Jul 31. Clin Exp Vaccine Res. 2019. PMID: 31406690 Free PMC article.

133

Non-invasive molecular imaging of immune cell dynamics for vaccine research.

Youn H, Hong KJ. Youn H, et al. Clin Exp Vaccine Res. 2019 Jul;8(2):89-93. doi: 10.7774/cevr.2019.8.2.89. Epub 2019 Jul 31. Clin Exp Vaccine Res. 2019. PMID: 31406689 Free PMC article. Review.

134

Absence of neutralizing activity in serum 1 year after successful treatment with antivirals and recovery from MERS in South Korea.

Choi JY, Oh JO, Ahn JY, Choi H, Kim JH, Seong H, Jeong SJ, Ku NS, Yeom JS, Choi JP. Choi JY, et al. Clin Exp Vaccine Res. 2019 Jan;8(1):86-88. doi: 10.7774/cevr.2019.8.1.86. Epub 2019 Jan 31. Clin Exp Vaccine Res. 2019. PMID: 30775355 Free PMC article.

135

Patterns and trends of malaria in 25 risk districts of Nepal from 2001 to 2017.

Gautam N, Kakchapati S, Shrestha S, Wanishsakpong W. Gautam N, et al. Clin Exp Vaccine Res. 2019 Jan;8(1):77-85. doi: 10.7774/cevr.2019.8.1.77. Epub 2019 Jan 31. Clin Exp Vaccine Res. 2019. PMID: 30775354 Free PMC article.

136

Development of a HA1-specific enzyme-linked immunosorbent assay against pandemic influenza virus A H1N1.

Shim DH, Kim MJ, Cha HR, Park ES, Kim AR, Park JH, Park HC, Song D, Lee JM. Shim DH, et al. Clin Exp Vaccine Res. 2019 Jan;8(1):70-76. doi: 10.7774/cevr.2019.8.1.70. Epub 2019 Jan 31. Clin Exp Vaccine Res. 2019. PMID: 30775353 Free PMC article.

137

Enzyme-linked immunosorbent assay for detecting anti-pertussis toxin antibody in mouse.

Choi GS, Huh DH, Han SB, Ahn DH, Kang KR, Kim JA, Choi BM, Kim HR, Kang JH. Choi GS, et al. Clin Exp Vaccine Res. 2019 Jan;8(1):64-69. doi: 10.7774/cevr.2019.8.1.64. Epub 2019 Jan 31. Clin Exp Vaccine Res. 2019. PMID: 30775352 Free PMC article.

138

Nucleoprotein vaccine induces cross-protective cytotoxic T lymphocytes against both lineages of influenza B virus.

Lee SY, Kang JO, Chang J. Lee SY, et al. Clin Exp Vaccine Res. 2019 Jan;8(1):54-63. doi: 10.7774/cevr.2019.8.1.54. Epub 2019 Jan 31. Clin Exp Vaccine Res. 2019. PMID: 30775351 Free PMC article.

139

Vaccine containing G protein fragment and recombinant baculovirus expressing M2 protein induces protective immunity to respiratory syncytial virus.

Jo YM, Kim J, Chang J. Jo YM, et al. Clin Exp Vaccine Res. 2019 Jan;8(1):43-53. doi: 10.7774/cevr.2019.8.1.43. Epub 2019 Jan 31. Clin Exp Vaccine Res. 2019. PMID: 30775350 Free PMC article.

140

Development and implementation of standardized method for detecting immunogenicity of acellular pertussis vaccines in Korea.

Park C, Huh DH, Han SB, Choi GS, Kang KR, Kim JA, Kang JH. Park C, et al. Clin Exp Vaccine Res. 2019 Jan;8(1):35-42. doi: 10.7774/cevr.2019.8.1.35. Epub 2019 Jan 31. Clin Exp Vaccine Res. 2019. PMID: 30775349 Free PMC article.

141

Expression and serological application of recombinant epitope-repeat protein carrying an immunodominant epitope of Newcastle disease virus nucleoprotein.

Gaikwad SS, Lee HJ, Kim JY, Choi KS. Gaikwad SS, et al. Clin Exp Vaccine Res. 2019 Jan;8(1):27-34. doi: 10.7774/cevr.2019.8.1.27. Epub 2019 Jan 31. Clin Exp Vaccine Res. 2019. PMID: 30775348 Free PMC article.

142

Rhoptry antigens as Toxoplasma gondii vaccine target.

Foroutan M, Ghaffarifar F, Sharifi Z, Dalimi A, Jorjani O. Foroutan M, et al. Clin Exp Vaccine Res. 2019 Jan;8(1):4-26. doi: 10.7774/cevr.2019.8.1.4. Epub 2019 Jan 31. Clin Exp Vaccine Res. 2019. PMID: 30775347 Free PMC article. Review.

143

A national project to build a business support facility for plant-derived vaccine.

Choi BH, Kim DY. Choi BH, et al. Clin Exp Vaccine Res. 2019 Jan;8(1):1-3. doi: 10.7774/cevr.2019.8.1.1. Epub 2019 Jan 31. Clin Exp Vaccine Res. 2019. PMID: 30775346 Free PMC article. No abstract available.

144

Organoid as a culture system for viral vaccine strains.

Hong KJ, Seo SH. Hong KJ, et al. Clin Exp Vaccine Res. 2018 Jul;7(2):145-148. doi: 10.7774/cevr.2018.7.2.145. Epub 2018 Jul 31. Clin Exp Vaccine Res. 2018. PMID: 30112354 Free PMC article.

145

Genetic identification and serological evaluation of commercial inactivated foot-and-mouth disease virus vaccine in pigs.

Je SH, Kwon T, Yoo SJ, Lee DU, Seo SW, Byun JJ, Shin JY, Lyoo YS. Je SH, et al. Clin Exp Vaccine Res. 2018 Jul;7(2):139-144. doi: 10.7774/cevr.2018.7.2.139. Epub 2018 Jul 31. Clin Exp Vaccine Res. 2018. PMID: 30112353 Free PMC article.

146

Development of dual reporter imaging system for Francisella tularensis to monitor the spatio-temporal pathogenesis and vaccine efficacy.

Kim YH, Park PG, Seo SH, Hong KJ, Youn H. Kim YH, et al. Clin Exp Vaccine Res. 2018 Jul;7(2):129-138. doi: 10.7774/cevr.2018.7.2.129. Epub 2018 Jul 31. Clin Exp Vaccine Res. 2018. PMID: 30112352 Free PMC article.

147

Purification and characterization of monoclonal IgG antibodies recognizing Ebola virus glycoprotein.

Han BS, Jang HY, Racine T, Qiu X, Sin JI. Han BS, et al. Clin Exp Vaccine Res. 2018 Jul;7(2):119-128. doi: 10.7774/cevr.2018.7.2.119. Epub 2018 Jul 31. Clin Exp Vaccine Res. 2018. PMID: 30112351 Free PMC article.

148

Evaluation of EZplex MTBC/NTM Real-Time PCR kit: diagnostic accuracy and efficacy in vaccination.

Lee S, Hwang KA, Ahn JH, Nam JH. Lee S, et al. Clin Exp Vaccine Res. 2018 Jul;7(2):111-118. doi: 10.7774/cevr.2018.7.2.111. Epub 2018 Jul 31. Clin Exp Vaccine Res. 2018. PMID: 30112350 Free PMC article.

149

Immunogenicity of a bivalent killed thimerosal-free oral cholera vaccine, Euvichol, in an animal model.

Lee EY, Lee S, Rho S, Kim JO, Choi SK, Lee YJ, Park JY, Song M, Yang JS. Lee EY, et al. Clin Exp Vaccine Res. 2018 Jul;7(2):104-110. doi: 10.7774/cevr.2018.7.2.104. Epub 2018 Jul 31. Clin Exp Vaccine Res. 2018. PMID: 30112349 Free PMC article.

150

Recent progress in microneme-based vaccines development against Toxoplasma gondii.

Foroutan M, Zaki L, Ghaffarifar F. Foroutan M, et al. Clin Exp Vaccine Res. 2018 Jul;7(2):93-103. doi: 10.7774/cevr.2018.7.2.93. Epub 2018 Jul 31. Clin Exp Vaccine Res. 2018. PMID: 30112348 Free PMC article. Review.

151

Strategies to maintain Korea's animal rabies non-occurrence status.

Yang DK, Kim HH, Cho IS. Yang DK, et al. Clin Exp Vaccine Res. 2018 Jul;7(2):87-92. doi: 10.7774/cevr.2018.7.2.87. Epub 2018 Jul 31. Clin Exp Vaccine Res. 2018. PMID: 30112347 Free PMC article. Review.

152

Evaluation of two different enzyme-linked immunosorbent assay for severe fever with thrombocytopenia syndrome virus diagnosis.

Yu MA, Jeong HW, Park SJ, Kim YI, Kwon HI, Kim EH, Si YJ, Yu KM, Robles NJ, Han HJ, Choi YK. Yu MA, et al. Clin Exp Vaccine Res. 2018 Jan;7(1):82-86. doi: 10.7774/cevr.2018.7.1.82. Epub 2018 Jan 29. Clin Exp Vaccine Res. 2018. PMID: 29399584 Free PMC article.

153

Status of group B streptococcal vaccine development.

Lin SM, Zhi Y, Ahn KB, Lim S, Seo HS. Lin SM, et al. Clin Exp Vaccine Res. 2018 Jan;7(1):76-81. doi: 10.7774/cevr.2018.7.1.76. Epub 2018 Jan 29. Clin Exp Vaccine Res. 2018. PMID: 29399583 Free PMC article.

154

Outbreak investigation of pertussis in an elementary school: a case-control study among vaccinated students.

Ryu S, Kim JJ, Chen MY, Jin H, Lee HK, Chun BC. Ryu S, et al. Clin Exp Vaccine Res. 2018 Jan;7(1):70-75. doi: 10.7774/cevr.2018.7.1.70. Epub 2018 Jan 29. Clin Exp Vaccine Res. 2018. PMID: 29399582 Free PMC article.

155

Efficacy of inactivated variant porcine epidemic diarrhea virus vaccines in growing pigs.

Lee SH, Yang DK, Kim HH, Cho IS. Lee SH, et al. Clin Exp Vaccine Res. 2018 Jan;7(1):61-69. doi: 10.7774/cevr.2018.7.1.61. Epub 2018 Jan 29. Clin Exp Vaccine Res. 2018. PMID: 29399581 Free PMC article.

156

Immunogenicity of the nanovaccine containing intimin recombinant protein in the BALB/c mice.

Hosseini ZS, Amani J, Baghbani Arani F, Nazarian S, Motamedi MJ, Shafighian F. Hosseini ZS, et al. Clin Exp Vaccine Res. 2018 Jan;7(1):51-60. doi: 10.7774/cevr.2018.7.1.51. Epub 2018 Jan 29. Clin Exp Vaccine Res. 2018. PMID: 29399580 Free PMC article.

157

Epidemiology of severe fever and thrombocytopenia syndrome virus infection and the need for therapeutics for the prevention.

Robles NJC, Han HJ, Park SJ, Choi YK. Robles NJC, et al. Clin Exp Vaccine Res. 2018 Jan;7(1):43-50. doi: 10.7774/cevr.2018.7.1.43. Epub 2018 Jan 29. Clin Exp Vaccine Res. 2018. PMID: 29399579 Free PMC article. Review.

158

Anti-infective potential of catechins and their derivatives against viral hepatitis.

Song JM. Song JM. Clin Exp Vaccine Res. 2018 Jan;7(1):37-42. doi: 10.7774/cevr.2018.7.1.37. Epub 2018 Jan 29. Clin Exp Vaccine Res. 2018. PMID: 29399578 Free PMC article. Review.

159

Calcium-dependent protein kinases are potential targets for Toxoplasma gondii vaccine.

Foroutan M, Ghaffarifar F. Foroutan M, et al. Clin Exp Vaccine Res. 2018 Jan;7(1):24-36. doi: 10.7774/cevr.2018.7.1.24. Epub 2018 Jan 29. Clin Exp Vaccine Res. 2018. PMID: 29399577 Free PMC article. Review.

160

Distinct features of dendritic cell-based immunotherapy as cancer vaccines.

Lee C, Lee M, Rhee I. Lee C, et al. Clin Exp Vaccine Res. 2018 Jan;7(1):16-23. doi: 10.7774/cevr.2018.7.1.16. Epub 2018 Jan 29. Clin Exp Vaccine Res. 2018. PMID: 29399576 Free PMC article. Review.

161

Challenges of influenza A viruses in humans and animals and current animal vaccines as an effective control measure.

Yoo SJ, Kwon T, Lyoo YS. Yoo SJ, et al. Clin Exp Vaccine Res. 2018 Jan;7(1):1-15. doi: 10.7774/cevr.2018.7.1.1. Epub 2018 Jan 29. Clin Exp Vaccine Res. 2018. PMID: 29399575 Free PMC article. Review.

162

Application of aptamers for assessment of vaccine efficacy.

Yoon SY, Gee G, Hong KJ, Seo SH. Yoon SY, et al. Clin Exp Vaccine Res. 2017 Jul;6(2):160-163. doi: 10.7774/cevr.2017.6.2.160. Epub 2017 Jul 26. Clin Exp Vaccine Res. 2017. PMID: 28775981 Free PMC article.

163

Microneedles: quick and easy delivery methods of vaccines.

Kwon KM, Lim SM, Choi S, Kim DH, Jin HE, Jee G, Hong KJ, Kim JY. Kwon KM, et al. Clin Exp Vaccine Res. 2017 Jul;6(2):156-159. doi: 10.7774/cevr.2017.6.2.156. Epub 2017 Jul 26. Clin Exp Vaccine Res. 2017. PMID: 28775980 Free PMC article.

164

Surveillance and compensation claims for adverse events following immunization from 2011 to 2016 in the Republic of Korea.

Kim MK, Lee YK, Kim TE, Kong I, Yang HJ, Suh ES. Kim MK, et al. Clin Exp Vaccine Res. 2017 Jul;6(2):146-155. doi: 10.7774/cevr.2017.6.2.146. Epub 2017 Jul 26. Clin Exp Vaccine Res. 2017. PMID: 28775979 Free PMC article.

165

Preferential production of IgM-secreting hybridomas by immunization with DNA vaccines coding for Ebola virus glycoprotein: use of protein boosting for IgG-secreting hybridoma production.

Lee SH, Han BS, Choe J, Sin JI. Lee SH, et al. Clin Exp Vaccine Res. 2017 Jul;6(2):135-145. doi: 10.7774/cevr.2017.6.2.135. Epub 2017 Jul 26. Clin Exp Vaccine Res. 2017. PMID: 28775978 Free PMC article.

166

A genetically modified rabies vaccine (ERAGS) induces protective immunity in dogs and cattle.

Yang DK, Kim HH, Lee SH, Jeong WH, Tark D, Cho IS. Yang DK, et al. Clin Exp Vaccine Res. 2017 Jul;6(2):128-134. doi: 10.7774/cevr.2017.6.2.128. Epub 2017 Jul 26. Clin Exp Vaccine Res. 2017. PMID: 28775977 Free PMC article.

167

Static model simulation for routine mumps vaccination in Japan: with a result of mumps-related complications in a Japanese community hospital.

Kitano T, Onaka M, Ishihara M, Nishiyama A, Hashimoto N, Yoshida S. Kitano T, et al. Clin Exp Vaccine Res. 2017 Jul;6(2):120-127. doi: 10.7774/cevr.2017.6.2.120. Epub 2017 Jul 26. Clin Exp Vaccine Res. 2017. PMID: 28775976 Free PMC article.

168

Mass vaccination has led to the elimination of rabies since 2014 in South Korea.

Yang DK, Kim HH, Lee KK, Yoo JY, Seomun H, Cho IS. Yang DK, et al. Clin Exp Vaccine Res. 2017 Jul;6(2):111-119. doi: 10.7774/cevr.2017.6.2.111. Epub 2017 Jul 26. Clin Exp Vaccine Res. 2017. PMID: 28775975 Free PMC article.

169

Animal models for dengue vaccine development and testing.

Na W, Yeom M, Choi IK, Yook H, Song D. Na W, et al. Clin Exp Vaccine Res. 2017 Jul;6(2):104-110. doi: 10.7774/cevr.2017.6.2.104. Epub 2017 Jul 26. Clin Exp Vaccine Res. 2017. PMID: 28775974 Free PMC article. Review.

170

Recent outbreaks of highly pathogenic avian influenza viruses in South Korea.

Kim HK, Jeong DG, Yoon SW. Kim HK, et al. Clin Exp Vaccine Res. 2017 Jul;6(2):95-103. doi: 10.7774/cevr.2017.6.2.95. Epub 2017 Jul 26. Clin Exp Vaccine Res. 2017. PMID: 28775973 Free PMC article. Review.

171

The significance of avian influenza virus mouse-adaptation and its application in characterizing the efficacy of new vaccines and therapeutic agents.

Choi WS, Lloren KKS, Baek YH, Song MS. Choi WS, et al. Clin Exp Vaccine Res. 2017 Jul;6(2):83-94. doi: 10.7774/cevr.2017.6.2.83. Epub 2017 Jul 26. Clin Exp Vaccine Res. 2017. PMID: 28775972 Free PMC article. Review.

172

Newcastle disease virus vectored vaccines as bivalent or antigen delivery vaccines.

Choi KS. Choi KS. Clin Exp Vaccine Res. 2017 Jul;6(2):72-82. doi: 10.7774/cevr.2017.6.2.72. Epub 2017 Jul 26. Clin Exp Vaccine Res. 2017. PMID: 28775971 Free PMC article. Review.

173

Clinical and Experimental Vaccine Research's promotion to internationally competitive journal evidenced by journal metrics.

Huh S. Huh S. Clin Exp Vaccine Res. 2017 Jul;6(2):67-71. doi: 10.7774/cevr.2017.6.2.67. Epub 2017 Jul 26. Clin Exp Vaccine Res. 2017. PMID: 28775970 Free PMC article. No abstract available.

174

Preparation and immunogenicity of influenza virus-like particles using nitrocellulose membrane filtration.

Park YC, Song JM. Park YC, et al. Clin Exp Vaccine Res. 2017 Jan;6(1):61-66. doi: 10.7774/cevr.2017.6.1.61. Epub 2017 Jan 25. Clin Exp Vaccine Res. 2017. PMID: 28168175 Free PMC article.

175

SH2 domain-containing adaptor protein B expressed in dendritic cells is involved in T-cell homeostasis by regulating dendritic cell-mediated Th2 immunity.

Ahmed MS, Kang MH, Lee E, Park Y, Jeong Y, Bae YS. Ahmed MS, et al. Clin Exp Vaccine Res. 2017 Jan;6(1):50-60. doi: 10.7774/cevr.2017.6.1.50. Epub 2017 Jan 25. Clin Exp Vaccine Res. 2017. PMID: 28168174 Free PMC article.

176

Trivalent M-related protein as a component of next generation group A streptococcal vaccines.

Courtney HS, Niedermeyer SE, Penfound TA, Hohn CM, Greeley A, Dale JB. Courtney HS, et al. Clin Exp Vaccine Res. 2017 Jan;6(1):45-49. doi: 10.7774/cevr.2017.6.1.45. Epub 2017 Jan 25. Clin Exp Vaccine Res. 2017. PMID: 28168173 Free PMC article.

177

Comparison of immunogenicity and safety of an influenza vaccine administered concomitantly with a 13-valent pneumococcal conjugate vaccine or 23-valent polysaccharide pneumococcal vaccine in the elderly.

Seo YB, Choi WS, Lee J, Song JY, Cheong HJ, Kim WJ. Seo YB, et al. Clin Exp Vaccine Res. 2017 Jan;6(1):38-44. doi: 10.7774/cevr.2017.6.1.38. Epub 2017 Jan 25. Clin Exp Vaccine Res. 2017. PMID: 28168172 Free PMC article.

178

Psychogenic illness following vaccination: exploratory study of mass vaccination against pandemic influenza A (H1N1) in 2009 in South Korea.

Yang TU, Kim HJ, Lee YK, Park YJ. Yang TU, et al. Clin Exp Vaccine Res. 2017 Jan;6(1):31-37. doi: 10.7774/cevr.2017.6.1.31. Epub 2017 Jan 25. Clin Exp Vaccine Res. 2017. PMID: 28168171 Free PMC article.

179

Tetanus-diphtheria-acellular pertussis vaccination for adults: an update.

Lee HJ, Choi JH. Lee HJ, et al. Clin Exp Vaccine Res. 2017 Jan;6(1):22-30. doi: 10.7774/cevr.2017.6.1.22. Epub 2017 Jan 25. Clin Exp Vaccine Res. 2017. PMID: 28168170 Free PMC article. Review.

180

The development of mucosal vaccines for both mucosal and systemic immune induction and the roles played by adjuvants.

Kim SH, Jang YS. Kim SH, et al. Clin Exp Vaccine Res. 2017 Jan;6(1):15-21. doi: 10.7774/cevr.2017.6.1.15. Epub 2017 Jan 25. Clin Exp Vaccine Res. 2017. PMID: 28168169 Free PMC article. Review.

181

Enterovirus 71 infection and vaccines.

Yi EJ, Shin YJ, Kim JH, Kim TG, Chang SY. Yi EJ, et al. Clin Exp Vaccine Res. 2017 Jan;6(1):4-14. doi: 10.7774/cevr.2017.6.1.4. Epub 2017 Jan 25. Clin Exp Vaccine Res. 2017. PMID: 28168168 Free PMC article. Review.

182

Challenges in the development of T-cell-based universal influenza vaccines.

Kang JO, Chang J. Kang JO, et al. Clin Exp Vaccine Res. 2017 Jan;6(1):1-3. doi: 10.7774/cevr.2017.6.1.1. Epub 2017 Jan 25. Clin Exp Vaccine Res. 2017. PMID: 28168167 Free PMC article. No abstract available.

183

A Bordetella pertussis proteoliposome induces protection in mice without affecting the immunogenicity of diphtheria and tetanus toxoids in a trivalent formulation.

Castillo SF, Chovel ML, Hernández NG, González LC, Blanco A, Hernández DS, Medina MF, Tito MÁ, Quiñoy JL. Castillo SF, et al. Clin Exp Vaccine Res. 2016 Jul;5(2):175-8. doi: 10.7774/cevr.2016.5.2.175. Epub 2016 Jul 29. Clin Exp Vaccine Res. 2016. PMID: 27489808 Free PMC article.

184

A recombinant rabies virus (ERAGS) for use in a bait vaccine for swine.

Yang DK, Kim HH, Choi SS, Lee SH, Cho IS. Yang DK, et al. Clin Exp Vaccine Res. 2016 Jul;5(2):169-74. doi: 10.7774/cevr.2016.5.2.169. Epub 2016 Jul 29. Clin Exp Vaccine Res. 2016. PMID: 27489807 Free PMC article.

185

Safety and immunogenicity of recombinant rabies virus (ERAGS) in mice and raccoon dogs.

Yang DK, Kim HH, Choi SS, Kim JT, Lee KB, Lee SH, Cho IS. Yang DK, et al. Clin Exp Vaccine Res. 2016 Jul;5(2):159-68. doi: 10.7774/cevr.2016.5.2.159. Epub 2016 Jul 29. Clin Exp Vaccine Res. 2016. PMID: 27489806 Free PMC article.

186

Protective efficacy and immune responses by homologous prime-booster immunizations of a novel inactivated Salmonella Gallinarum vaccine candidate.

Won G, Chaudhari AA, Lee JH. Won G, et al. Clin Exp Vaccine Res. 2016 Jul;5(2):148-58. doi: 10.7774/cevr.2016.5.2.148. Epub 2016 Jul 29. Clin Exp Vaccine Res. 2016. PMID: 27489805 Free PMC article.

187

QS-21 enhances the early antibody response to oil adjuvant foot-and-mouth disease vaccine in cattle.

Çokçalışkan C, Türkoğlu T, Sareyyüpoğlu B, Uzunlu E, Babak A, Özbilge BB, Gülyaz V. Çokçalışkan C, et al. Clin Exp Vaccine Res. 2016 Jul;5(2):138-47. doi: 10.7774/cevr.2016.5.2.138. Epub 2016 Jul 29. Clin Exp Vaccine Res. 2016. PMID: 27489804 Free PMC article.

188

An oral Aujeszky's disease vaccine (YS-400) induces neutralizing antibody in pigs.

Yang DK, Kim HH, Choi SS, Hyun BH, Song JY. Yang DK, et al. Clin Exp Vaccine Res. 2016 Jul;5(2):132-7. doi: 10.7774/cevr.2016.5.2.132. Epub 2016 Jul 29. Clin Exp Vaccine Res. 2016. PMID: 27489803 Free PMC article.

189

Vaccination strategies in patients with solid organ transplant: evidences and future perspectives.

Kim YJ, Kim SI. Kim YJ, et al. Clin Exp Vaccine Res. 2016 Jul;5(2):125-31. doi: 10.7774/cevr.2016.5.2.125. Epub 2016 Jul 29. Clin Exp Vaccine Res. 2016. PMID: 27489802 Free PMC article. Review.

190

Influenza virus vaccine for neglected hosts: horses and dogs.

Na W, Yeom M, Yuk H, Moon H, Kang B, Song D. Na W, et al. Clin Exp Vaccine Res. 2016 Jul;5(2):117-24. doi: 10.7774/cevr.2016.5.2.117. Epub 2016 Jul 29. Clin Exp Vaccine Res. 2016. PMID: 27489801 Free PMC article. Review.

191

Development of vaccines to Mycobacterium avium subsp. paratuberculosis infection.

Park HT, Yoo HS. Park HT, et al. Clin Exp Vaccine Res. 2016 Jul;5(2):108-16. doi: 10.7774/cevr.2016.5.2.108. Epub 2016 Jul 29. Clin Exp Vaccine Res. 2016. PMID: 27489800 Free PMC article. Review.

192

Accelerating the development of a group A Streptococcus vaccine: an urgent public health need.

Excler JL, Kim JH. Excler JL, et al. Clin Exp Vaccine Res. 2016 Jul;5(2):101-7. doi: 10.7774/cevr.2016.5.2.101. Epub 2016 Jul 29. Clin Exp Vaccine Res. 2016. PMID: 27489799 Free PMC article. Review.

193

Prospects for dengue vaccines for travelers.

Lim SK, Lee YS, Namkung S, Lim JK, Yoon IK. Lim SK, et al. Clin Exp Vaccine Res. 2016 Jul;5(2):89-100. doi: 10.7774/cevr.2016.5.2.89. Epub 2016 Jul 29. Clin Exp Vaccine Res. 2016. PMID: 27489798 Free PMC article. Review.

194

Novel foot-and-mouth disease virus in Korea, July-August 2014.

Park JH, Tark D, Lee KN, Lee SY, Ko MK, Lee HS, Kim SM, Ko YJ, Seo MG, Chun JE, Lee MH, Kim B. Park JH, et al. Clin Exp Vaccine Res. 2016 Jan;5(1):83-7. doi: 10.7774/cevr.2016.5.1.83. Epub 2016 Jan 27. Clin Exp Vaccine Res. 2016. PMID: 26866028 Free PMC article.

195

In silico analysis of Brucella abortus Omp2b and in vitro expression of SOmp2b.

Golshani M, Vaeznia N, Sahmani M, Bouzari S. Golshani M, et al. Clin Exp Vaccine Res. 2016 Jan;5(1):75-82. doi: 10.7774/cevr.2016.5.1.75. Epub 2016 Jan 27. Clin Exp Vaccine Res. 2016. PMID: 26866027 Free PMC article.

196

Augmented immune responses in pigs immunized with an inactivated porcine reproductive and respiratory syndrome virus containing the deglycosylated glycoprotein 5 under field conditions.

Lee JA, Lee NH, Lee JB, Park SY, Song CS, Choi IS, Lee SW. Lee JA, et al. Clin Exp Vaccine Res. 2016 Jan;5(1):70-4. doi: 10.7774/cevr.2016.5.1.70. Epub 2016 Jan 27. Clin Exp Vaccine Res. 2016. PMID: 26866026 Free PMC article.

197

Immunogenicity and efficacy of Rabivac vaccine for animal rabies control in Morocco.

Darkaoui S, Fassi Fihri O, Schereffer JL, Aboulfidaa N, Wasniewski M, Zouine K, Bouslikhane M, Yahia KI, Cliquet F. Darkaoui S, et al. Clin Exp Vaccine Res. 2016 Jan;5(1):60-9. doi: 10.7774/cevr.2016.5.1.60. Epub 2016 Jan 27. Clin Exp Vaccine Res. 2016. PMID: 26866025 Free PMC article.

198

A potent multivalent vaccine for modulation of immune system in atherosclerosis: an in silico approach.

Karkhah A, Amani J. Karkhah A, et al. Clin Exp Vaccine Res. 2016 Jan;5(1):50-9. doi: 10.7774/cevr.2016.5.1.50. Epub 2016 Jan 27. Clin Exp Vaccine Res. 2016. PMID: 26866024 Free PMC article.

199

In silico analysis of an envelope domain III-based multivalent fusion protein as a potential dengue vaccine candidate.

Fahimi H, Sadeghizadeh M, Mohammadipour M. Fahimi H, et al. Clin Exp Vaccine Res. 2016 Jan;5(1):41-9. doi: 10.7774/cevr.2016.5.1.41. Epub 2016 Jan 27. Clin Exp Vaccine Res. 2016. PMID: 26866023 Free PMC article.

200

Assessment of immunological markers and booster effects of Ag85B peptides, Ag85B, and BCG in blood of BCG vaccinated children: a preliminary report.

Husain AA, Daginawla HF, Singh L, Kashyap RS. Husain AA, et al. Clin Exp Vaccine Res. 2016 Jan;5(1):31-40. doi: 10.7774/cevr.2016.5.1.31. Epub 2016 Jan 27. Clin Exp Vaccine Res. 2016. PMID: 26866022 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

297 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

297 results

Results by year